NCT05257135Recruiting
A Clinico-biological Database in Cachexia in Patients With Colon Cancer
Development of a Prospective Clinico-biological Database in Cachexia in Patients With Colon Cancer
Source: ClinicalTrials.gov · Last updated 13 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Creation of a prospective clinico-biological database dedicated to cachexia and undernutrition in order to carry out future research projects, to improve our knowledge of colon cancer and cachexia and to optimize the therapeutic management of patients
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- First submitted
- 16 Feb 2022
- Start date
- 23 Dec 2021
- Primary completion date
- May 2026
- Lead sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Diseases
- Colorectal cancer
- NCT number
- NCT05257135
What you commit to
- Study type: Interventional
- Planned participants: 150
- From 23 Dec 2021 to the primary completion date, May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient requiring radiotherapy
Other illness
- Patient requiring surgery (for treatment of colon cancer or metastasis)
Other
- Patient with exclusive peritoneal carcinomatosis
- Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
- Pregnant and/ or breastfeeding women
- Patient cared for an emergency context
Who the study is looking for
- Age ≥ 18 years old,
- Patient treated at the Montpellier Regional Cancer Institute for colon cancer not eligible for surgery (of the primary tumor or associated metastases), whether undergoing treatment or not,
- Patient requiring treatment for colon cancer (chemotherapy, targeted therapy, etc.),
- Patient having accepted the constraints of the research and the blood samples planned for the research
- Patient affiliated to Social Protection system
- Informed consent form signed
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Regional Du Cancer de Montpellier Coordinator of this site? Confirm its status | Montpellier | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.